Efficacy News and Research

RSS
FDA extends review period for linaclotide NDA to treat constipation

FDA extends review period for linaclotide NDA to treat constipation

Scripps Florida scientist to develop new tests for aging and stress-associated diseases

Scripps Florida scientist to develop new tests for aging and stress-associated diseases

Sequana Medical's ALFApump System safe and effective in managing ascites

Sequana Medical's ALFApump System safe and effective in managing ascites

Positive results from Alnylam’s ALN-PCS Phase I trial on severe hypercholesterolemia

Positive results from Alnylam’s ALN-PCS Phase I trial on severe hypercholesterolemia

New data provides hope for HCV non-responders

New data provides hope for HCV non-responders

New data shows consolidation of interferon-free revolution in HCV treatment

New data shows consolidation of interferon-free revolution in HCV treatment

Study shows efficacy of Infant Behavior, Cry and Sleep Clinic's model of integrated care

Study shows efficacy of Infant Behavior, Cry and Sleep Clinic's model of integrated care

Patients with head and neck cancer can benefit from swallowing exercises

Patients with head and neck cancer can benefit from swallowing exercises

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

BuruliVac project getting closer to a vaccine

BuruliVac project getting closer to a vaccine

NSCLC patients with EGFR mutations benefit from erlotinib-first regimen

NSCLC patients with EGFR mutations benefit from erlotinib-first regimen

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO to host presentation of results from two clinical trials on neovascular AMD

Autologous BMMNCs reduce vascular growth in patients with diabetes

Autologous BMMNCs reduce vascular growth in patients with diabetes

Results from Presidio’s PPI-668 Phase 1a-1b trial on chronic HCV

Results from Presidio’s PPI-668 Phase 1a-1b trial on chronic HCV

Positive results from CrystalGenomics’ CG100649 Phase 2b OA study

Positive results from CrystalGenomics’ CG100649 Phase 2b OA study

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Medical journals facing raft of ethical, transparency challenges

Medical journals facing raft of ethical, transparency challenges

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

NSCLC drug regimen approved in 2006 does not improve survival for older patients

NSCLC drug regimen approved in 2006 does not improve survival for older patients

Autologous HSPPC-96 vaccine clinically beneficial for GBM patients

Autologous HSPPC-96 vaccine clinically beneficial for GBM patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.